Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

EU approval granted for Humalog

May 10, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Bone-regulatory activity of oncostatin M reported

May 10, 1996

F-792: Truncated oxytocin analogue from Ferring

May 3, 1996

Testosterone enanthate effective in male contraception study

May 3, 1996

Seprafilm approval recommended in U.S.

May 3, 1996

Genistein claimed for menopausal and PMS symptoms

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...